The emerging therapy of this peptide represents a exciting advance in the handling of type 2 diabetes. Different to existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide542080.sharebyblog.com/41889978/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment